Yuri Shunsuke, Nishikawa Masaki, Yanagawa Naomi, Jo Oak D, Yanagawa Norimoto
Medical and Research Services, Greater Los Angeles Veterans Affairs Healthcare System at Sepulveda, North Hills, California, United States of America; University of California at Los Angeles, David Geffen School of Medicine, Los Angeles, California, United States of America.
PLoS One. 2015 Jun 15;10(6):e0129242. doi: 10.1371/journal.pone.0129242. eCollection 2015.
Knowledge on how to maintain and expand nephron progenitor cells (NPC) in vitro is important to provide a potentially valuable source for kidney replacement therapies. In our present study, we examined the possibility of optimizing NPC maintenance in the "re-aggregate" system. We found that Six2-expressing (Six2(+))-NPC could be maintained in aggregates reconstituted with dispersed cells from E12.5 mouse embryonic kidneys for at least up to 21 days in culture. The maintenance of Six2(+)-NPC required the presence of ureteric bud cells. The number of Six2(+)-NPC increased by more than 20-fold at day 21, but plateaued after day 14. In an attempt to further sustain NPC proliferation by passage subculture, we found that the new (P1) aggregates reconstituted from the original (P0) aggregates failed to maintain NPC. However, based on the similarity between P1 aggregates and aggregates derived from E15.5 embryonic kidneys, we suspected that the differentiated NPC in P1 aggregates may interfere with NPC maintenance. In support of this notion, we found that preventing NPC differentiation by DAPT, a γ-secretase inhibitor that inhibits Notch signaling pathway, was effective to maintain and expand Six2(+)-NPC in P1 aggregates by up to 65-fold. The Six2(+)-NPC in P1 aggregates retained their potential to epithelialize upon exposure to Wnt signal. In conclusion, we demonstrated in our present study that the "re-aggregation" system can be useful for in vitro maintenance of NPC when combined with γ-secretase inhibitor.
了解如何在体外维持和扩增肾祖细胞(NPC)对于为肾脏替代疗法提供潜在有价值的来源非常重要。在我们目前的研究中,我们研究了在“重新聚集”系统中优化NPC维持的可能性。我们发现,表达Six2(Six2(+))的NPC可以在用来自E12.5小鼠胚胎肾脏的分散细胞重构的聚集体中维持至少长达21天的培养。Six2(+)NPC的维持需要输尿管芽细胞的存在。Six2(+)NPC的数量在第21天增加了20多倍,但在第14天后趋于平稳。为了通过传代培养进一步维持NPC增殖,我们发现从原始(P0)聚集体重构的新(P1)聚集体未能维持NPC。然而,基于P1聚集体与来自E15.5胚胎肾脏的聚集体之间的相似性,我们怀疑P1聚集体中分化的NPC可能会干扰NPC的维持。支持这一观点的是,我们发现用抑制Notch信号通路的γ-分泌酶抑制剂DAPT阻止NPC分化,有效地在P1聚集体中维持和扩增Six2(+)NPC达65倍。P1聚集体中的Six2(+)NPC在暴露于Wnt信号时保留了上皮化的潜力。总之,我们在目前的研究中证明,当与γ-分泌酶抑制剂联合使用时,“重新聚集”系统可用于NPC的体外维持。